Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 233

1.

Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide.

Blumsohn A, Marin F, Nickelsen T, Brixen K, Sigurdsson G, González de la Vera J, Boonen S, Liu-Léage S, Barker C, Eastell R; EUROFORS Study Group..

Osteoporos Int. 2011 Jun;22(6):1935-46. doi: 10.1007/s00198-010-1379-y. Epub 2010 Oct 12.

2.

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL; SCOUT Investigators..

N Engl J Med. 2010 Sep 2;363(10):905-17. doi: 10.1056/NEJMoa1003114.

3.

Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS.

Lyritis G, Marin F, Barker C, Pfeifer M, Farrerons J, Brixen K, del Pino J, Keen R, Nickelsen TN; EUROFORS Study Group..

Curr Med Res Opin. 2010 Aug;26(8):1799-807. doi: 10.1185/03007995.2010.488516.

PMID:
20482322
4.

Bone density after teriparatide in patients with or without prior antiresorptive treatment: one-year results from the EUROFORS study.

Minne H, Audran M, Simões ME, Obermayer-Pietsch B, Sigurðsson G, Marín F, Dalsky GP, Nickelsen T; EUROFORS Study Group..

Curr Med Res Opin. 2008 Nov;24(11):3117-28. doi: 10.1185/03007990802466595. Epub 2008 Oct 6.

PMID:
18838053
5.

The effects of tibolone in older postmenopausal women.

Cummings SR, Ettinger B, Delmas PD, Kenemans P, Stathopoulos V, Verweij P, Mol-Arts M, Kloosterboer L, Mosca L, Christiansen C, Bilezikian J, Kerzberg EM, Johnson S, Zanchetta J, Grobbee DE, Seifert W, Eastell R; LIFT Trial Investigators..

N Engl J Med. 2008 Aug 14;359(7):697-708. doi: 10.1056/NEJMoa0800743.

6.

Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment.

Obermayer-Pietsch BM, Marin F, McCloskey EV, Hadji P, Farrerons J, Boonen S, Audran M, Barker C, Anastasilakis AD, Fraser WD, Nickelsen T; EUROFORS Investigators..

J Bone Miner Res. 2008 Oct;23(10):1591-600. doi: 10.1359/jbmr.080506.

7.

Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis.

Boonen S, Marin F, Obermayer-Pietsch B, Simões ME, Barker C, Glass EV, Hadji P, Lyritis G, Oertel H, Nickelsen T, McCloskey EV; EUROFORS Investigators..

J Clin Endocrinol Metab. 2008 Mar;93(3):852-60. Epub 2007 Dec 26.

PMID:
18160462
8.

Effects of acetylsalicylic acid on ascorbic acid concentrations in plasma, gastric mucosa, gastric juice and urine--a double-blind study in healthy subjects.

Schulz HU, Schürer M, Krupp S, Dammann HG, Timm J, Gessner U.

Int J Clin Pharmacol Ther. 2004 Sep;42(9):481-7.

PMID:
15487806
9.

Sucralfate therapy in NSAID bleeding gastropathy.

Malagelada JR, Rodríguez de la Serna A, Dammann HG, Pons M, Armas C, Sala M, Tena X, Celdrán E, Mesa A.

Clin Gastroenterol Hepatol. 2003 Jan;1(1):51-6.

PMID:
15017517
10.

Effects of buffered and plain acetylsalicylic acid formulations with and without ascorbic acid on gastric mucosa in healthy subjects.

Dammann HG, Saleki M, Torz M, Schulz HU, Krupp S, Schürer M, Timm J, Gessner U.

Aliment Pharmacol Ther. 2004 Feb 1;19(3):367-74.

PMID:
14984384
11.

Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration.

Dammann HG, Fölsch UR, Hahn EG, von Kleist DH, Klör HU, Kirchner T, Strobel S, Kist M.

Helicobacter. 2000 Mar;5(1):41-51.

PMID:
10672051
12.

Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.

Dammann HG, Burkhardt F.

Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1277-82.

PMID:
10563540
13.

The effects of oral rabeprazole on endocrine and gastric secretory function in healthy volunteers.

Dammann HG, Burkhardt F, Wolf N.

Aliment Pharmacol Ther. 1999 Sep;13(9):1195-203.

14.

Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions.

Dammann HG, Burkhardt F, Wolf N.

Aliment Pharmacol Ther. 1999 Aug;13(8):1109-14.

15.

Impact of ELISA and immunoblot as diagnostic tools one year after eradication of Helicobacter pylori in a multicentre treatment study.

Kist M, Strobel S, Kirchner T, Dammann HG.

FEMS Immunol Med Microbiol. 1999 Jun;24(2):239-42.

16.
17.

Functional analysis of the catalytic subunit of Dictyostelium PKA in vivo.

Dammann H, Traincard F, Anjard C, van Bemmelen MX, Reymond C, Véron M.

Mech Dev. 1998 Mar;72(1-2):149-57.

18.

Overexpression, purification and characterization of Dictyostelium calcineurin A.

Hellstern S, Dammann H, Husain Q, Mutzel R.

Res Microbiol. 1997 May;148(4):335-43.

PMID:
9765812
19.

Lansoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.

Dammann HG, Fuchs W, Richter G, Burkhardt F, Wolf N, Walter TA.

Aliment Pharmacol Ther. 1997 Apr;11(2):359-64.

20.

Primary structure, expression and developmental regulation of a Dictyostelium calcineurin A homologue.

Dammann H, Hellstern S, Husain Q, Mutzel R.

Eur J Biochem. 1996 Jun 1;238(2):391-9.

Supplemental Content

Loading ...
Support Center